Volume 131, Issue 1, Pages (October 2007)

Slides:



Advertisements
Similar presentations
Volume 34, Issue 3, Pages (March 2011)
Advertisements

Nienke van der Stoep, James R Gorman, Frederick W Alt  Immunity 
Volume 10, Issue 5, Pages (May 1999)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 18, Issue 5, Pages (May 2003)
Volume 5, Issue 3, Pages (September 1996)
Volume 18, Issue 6, Pages (June 2003)
Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission  Yongjun Tian,
Volume 15, Issue 1, Pages (July 2001)
Volume 11, Issue 2, Pages (August 1999)
Volume 11, Issue 5, Pages (November 1999)
Volume 129, Issue 3, Pages (May 2007)
Volume 30, Issue 1, Pages (January 2009)
Redundant and Unique Roles of Two Enhancer Elements in the TCRγ Locus in Gene Regulation and γδ T Cell Development  Na Xiong, Chulho Kang, David H Raulet 
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Thorsten Buch, Frédéric Rieux-Laucat, Irmgard Förster, Klaus Rajewsky 
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor  Julien C. Marie,
Volume 9, Issue 2, Pages (February 2011)
Volume 10, Issue 5, Pages (November 2002)
Balthazar B Cazac, Jürgen Roes  Immunity 
PU.1/Spi-B Regulation of c-rel Is Essential for Mature B Cell Survival
Volume 19, Issue 2, Pages (August 2003)
MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb  Changchun Xiao, Dinis Pedro Calado, Gunther Galler, To-Ha Thai, Heide Christine.
Positive Selection from Newly Formed to Marginal Zone B Cells Depends on the Rate of Clonal Production, CD19, and btk  Flavius Martin, John F. Kearney 
Volume 137, Issue 1, Pages (July 2009)
Volume 24, Issue 3, Pages (March 2006)
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 44, Issue 6, Pages (June 2016)
Volume 10, Issue 5, Pages (May 1999)
Volume 18, Issue 6, Pages (December 2010)
CD22 is a negative regulator of B-cell receptor signalling
Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Volume 37, Issue 1, Pages (January 2010)
Manfred Kraus, Marat B. Alimzhanov, Nikolaus Rajewsky, Klaus Rajewsky 
MicroRNA Control in the Immune System: Basic Principles
Both E12 and E47 Allow Commitment to the B Cell Lineage
Volume 4, Issue 4, Pages (April 1996)
Volume 16, Issue 5, Pages (May 2002)
Volume 41, Issue 4, Pages (October 2014)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 17, Issue 5, Pages (November 2009)
Volume 24, Issue 6, Pages (June 2006)
Volume 36, Issue 1, Pages (January 2012)
MicroRNA Destabilization Enables Dynamic Regulation of the miR-16 Family in Response to Cell-Cycle Changes  Olivia S. Rissland, Sue-Jean Hong, David P.
Volume 19, Issue 4, Pages (October 2003)
Volume 27, Issue 5, Pages (November 2007)
Volume 27, Issue 5, Pages (November 2007)
Volume 27, Issue 1, Pages (July 2007)
Volume 31, Issue 2, Pages (August 2009)
Volume 25, Issue 1, Pages (July 2006)
Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells  Daphna Nachmani, Noam Stern-Ginossar,
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Volume 17, Issue 2, Pages (August 2015)
Volume 23, Issue 3, Pages (September 2005)
Volume 39, Issue 1, Pages (July 2013)
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region  Zi Chun Hua, Sue.
Volume 31, Issue 6, Pages (December 2009)
Volume 22, Issue 9, Pages (September 2014)
Volume 14, Issue 1, Pages (January 2001)
Mary O'Riordan, Rudolf Grosschedl  Immunity 
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Volume 28, Issue 5, Pages (May 2008)
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Volume 33, Issue 1, Pages (July 2010)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Volume 21, Issue 6, Pages (June 2012)
Zhen Zhang, Jamie M. Verheyden, John A. Hassell, Xin Sun 
Volume 11, Issue 2, Pages (August 1999)
Presentation transcript:

Volume 131, Issue 1, Pages 146-159 (October 2007) MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb  Changchun Xiao, Dinis Pedro Calado, Gunther Galler, To-Ha Thai, Heide Christine Patterson, Jing Wang, Nikolaus Rajewsky, Timothy P. Bender, Klaus Rajewsky  Cell  Volume 131, Issue 1, Pages 146-159 (October 2007) DOI: 10.1016/j.cell.2007.07.021 Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 1 MiR-150 Regulates c-Myb Expression through Its 3′UTR (A) Expression of miR-150 and c-Myb during B and T cell development was determined by northern blot and western blot, respectively. The miR-150/U6 ratio in CD8 T cells and the c-Myb/β-actin ratio in pro-B cells were arbitrarily set at 1. (B) The c-Myb 3′UTR contains three predicted miR-150 binding sites. Upper panel, alignment of the seed regions of the miR-150 sites with miR-150; lower panel, the c-Myb 3′UTR and its mutants. Numbers indicate positions of nucleotides. Crosses indicate the three-nucleotide mutation depicted in the upper panel. (C) A scheme of the psiCHECK2 reporter vector used in (D) and (E). Rluc, Renilla luciferase; Luc, firefly luciferase; and pA, polyadenylation signal. (D) MiR-150 downregulates the expression of a reporter gene containing the c-Myb 3′UTR. 2x mir150, two sites perfectly complementary to miR-150; pCXN2, the vector used to transiently express miRNAs. (E) Sites 2 and 3 mediate the inhibitory effect of miR-150 on the c-Myb 3′UTR. The reporter assays in (D) and (E) were performed three times, with essentially identical results. The Rluc/Luc ratio was arbitrarily set at 1 for all transfections with the empty pCXN2 vector, which was labeled as “vector” in (D) and “-” in (E). Data are presented as mean ± SD in (D) and (E). (F) Transient expression of miR-150 and miR-191 in HEK293T cells, as detected by northern blots. Numbers indicate the marker length in nucleotides. Cell 2007 131, 146-159DOI: (10.1016/j.cell.2007.07.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 2 Deficiency of MiR-150 Causes B1 Cell Expansion (A) Generation of mir150−/− mice by homologous recombination. A 679 bp miR150 encoding region together with a pGK-Neo cassette inserted next to it were flanked by loxP sites, and both were removed in the mouse germline by breeding heterozygous mice to deleter-Cre mice. (B) Detection of miR-150 in wild-type and mutant mice by northern blot analysis of spleen, mesenteric lymph node (mLN), and thymus. (C and D) B1 cell expansion in the spleen and peritoneal cavity of mir150−/− mice, examined at the age of 6–10 weeks. Each dot in (D) represents one mouse examined. KO, mir150−/−; WT, wild-type. Bars indicate mean values. Cell 2007 131, 146-159DOI: (10.1016/j.cell.2007.07.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 3 Enhanced Humoral Immune Responses in mir150−/− Mice (A) Changes of miR-150 levels in B cells upon activation. Purified B cells pooled from ten B6 mice were activated in vitro with indicated stimuli for the indicated time, and miR-150 and U6 levels were determined by northern blots. Twenty micrograms of total RNA was used for each sample. The reduction in miR-150 and U6 abundance was partly due to increased RNA content in activated B cells. (B) Enhanced upregulation of c-Myb in activated mir150−/− B cells. Purified B cells pooled from five mice per genotype were activated in vitro with 10 μg/ml anti-IgM for the indicated time. c-Myb, Bcl2, and β-actin levels were determined by western blot. Asterisks indicate nonspecific bands. The c-Myb/β-actin and Bcl2/β-actin ratio in activated mir150+/+ B cells at day 2 was arbitrarily set at 1. (C) Cell-cycle analysis of in vitro-activated B cells as described in (B). Note that the mir150−/− culture contained less dead cells (Sub-G0) on day 3. Five wild-type and six mir150−/− mice were analyzed, with similar results. (D) Increased serum immunoglobulin levels in unimmunized mir150−/− mice. Fifteen mice per genotype were bled at the age of 8–10 weeks, and serum Ig levels were determined by ELISA. (E) Enhanced T-dependent response in mir150−/− mice. Six mir150−/− mice and nine wild-type mice were immunized with 5 μg alum-precipitated NP36-CGG intraperitoneally at the age of 10 weeks and bled at the indicated time points. The levels of NP-specific Ig were determined by ELISA. Bars indicate geometric mean values in (D) and (E). Cell 2007 131, 146-159DOI: (10.1016/j.cell.2007.07.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 4 Ectopic MiR-150 Expression Impairs B Cell Development (A) Scheme of Rosa26 locus targeting. The mir150 genomic DNA includes the mir150 stem loop, a 136 bp 5′ flanking sequence, and a 130 bp 3′ flanking sequence. Both deleter-Cre and deleter-Flpe express their respective recombinases early during embryogenesis and delete in the germline. For both mir150-EGFP Tg and mir150 Tg, the CAG promoter drives transcription in all cells/tissues. (B) Ectopic miR-150 expression in tissues of mir150-EGFP Tg/Tg mice was determined by northern blot. The miR-150/U6 ratio in wild-type CD4 T cells was arbitrarily set at 1. (C) Ectopic miR-150 expression in thymocytes was determined by northern blot. Note that the ectopic expression level was below the endogenous expression level in naive CD4 T cells, whose miR-150/U6 ratio was arbitrarily set at 1. (D) Ectopic miR-150 expression repressed c-Myb protein levels in thymocytes. c-Myb and β-actin levels were determined by western blot, and the c-Myb/β-actin ratio in control thymocytes was arbitrarily set at 1. (E) Average miR-150/U6 and c-Myb/β-actin ratios in thymocytes of mice of indicated genotypes. Numbers above (upper panel) or inside (lower panel) bars indicate the numbers of mice examined. Mice were examined at the age of 4–41 weeks, and the miR-150 and c-Myb levels didn't change over age. Data are presented as mean ± SD. (F) B cell numbers in the spleen of 3- to 12-week-old mice ectopically expressing miR-150 were reduced. Each dot represents one mouse examined. (G) Cell numbers of B cell subsets in the spleen and peritoneal cavity of 18- to 41-week-old mice of indicated genotypes. Bars indicate mean values. (H) The pro- to pre-B cell transition in the bone marrow (BM) of mice ectopically expressing miR-150 was impaired. Five mice per genotype were analyzed at the age of 5–12 weeks, with similar block at pro- to pre-B transition. Older mir150 Tg/Tg mice exhibited more immature and mature B cells in the bone marrow than the 5.4-week-old mir150 Tg/Tg mouse shown in this figure. Cell 2007 131, 146-159DOI: (10.1016/j.cell.2007.07.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 5 Ectopic MiR-150 Expression Increases Cell Death of In Vitro-Cultured Pro-B Cells (A) Cell-cycle analysis of in vitro-cultured bone marrow pro-B cells. Note that the mir150-EGFP Tg/Tg culture contained more dead cells (Sub-G0). This analysis was performed for in vitro pro-B culture experiment 1 and 3 listed in Figure S6A, with similar results. (B) Growth curve of FACS-sorted bone marrow pro-B cells (B220+cKit+CD25−) in in vitro culture. Note the dose-dependent reduction of cell numbers for pro-B cells expressing miR-150. Two mice per genotype were examined. (C) Expression of miR-150 and c-Myb in in vitro-cultured pro-B cells as determined by northern and western blots, respectively. The miR-150/U6 ratio in splenic B cells and the c-Myb/β-actin ratio in control pro-B cells were arbitrarily set at 1. This experiment was performed for in vitro pro-B culture experiment 1 and 3 listed in Figure S6A, with similar results. Cell 2007 131, 146-159DOI: (10.1016/j.cell.2007.07.021) Copyright © 2007 Elsevier Inc. Terms and Conditions

Figure 6 Impaired B Cell Development and Reduced B1 Cell Numbers in c-Myb Heterozygous Mice (A) c-Myb protein levels in c-Myb+/− mice were determined by western blot. The highest c-Myb/β-actin ratio among wild-type mice was arbitrarily set at 1. (B) Average c-Myb protein levels in thymocytes of c-Myb+/− mice. The average c-Myb/β-actin ratio in c-Myb+/+ thymocytes was arbitrarily set at 1. Numbers inside bars indicate the numbers of mice examined. Two mice per genotype were analyzed at 10 weeks (shown in [A]), and the other two per genotype were analyzed at 26 days with similar results. Data are presented as mean ± SD. (C) Reduced B cell numbers in the spleen of 2-week-old c-Myb+/− mice. Each dot represents one mouse examined. Bars indicate mean values. (D) The pro- to pre-B cell transition in the bone marrow (BM) of c-Myb+/− mice was impaired. Five mice per genotype were analyzed at the age of 2 weeks, with similar results. (E and F) Reduced B1 cells in the spleen and peritoneal cavity of c-Myb+/− mice, examined at the age of 10–16 weeks. Each dot in (F) represents one mouse examined. Bars indicate mean values. Cell 2007 131, 146-159DOI: (10.1016/j.cell.2007.07.021) Copyright © 2007 Elsevier Inc. Terms and Conditions